In vitro-transfusional model for red-blood-cell study: the advantage of lowering hematocrit.
Journal
Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
11
04
2022
accepted:
26
09
2022
medline:
13
7
2023
pubmed:
9
11
2022
entrez:
8
11
2022
Statut:
ppublish
Résumé
The quality of red blood cells (RBCs) stored in red cell concentrates (RCCs) is influenced by processing, storage and donor characteristics, and can have a clinical impact on transfused patients. To evaluate RBC properties and their potential impact in a transfusion setting, a simple in vitro-transfusional model has been developed. Transfusion was simulated by mixing a washed RBC pool from two male-derived RCCs stored at 4°C with a pool of 15 male-derived fresh frozen plasma (FFP) units, representing the recipient, at a hematocrit (HCT) of 30% ("control" setting) or 5% (alternative model). The mixtures were incubated at 37°C, 5% of CO The 5%-HCT model restored the 2,3-DPG level and maintained the ATP level. Furthermore, glucose consumption and corresponding lactate production were increased in the 5%- vs the 30%-HCT condition. Lower hemolysis was observed with 5%-HCT, but only at day 2. However, morphological analysis by digital holographic microscopy (DHM) revealed a decreased fraction of discocytes at 5% rather than at 30% of HCT at storage day 2 but at day 43, the trend was inverted. Concordantly, RBCs incubated at 5% of HCT were more deformable than at 30% at day 43 (p<0.0001). Higher metabolic activity of RBCs in the 5%-HCT condition was promoted by a higher glucose availability and limited cell-waste accumulation. The conditions of the new proposed model thus enabled rejuvenation of RBCs and maintained them in a physiological-close state in contrast to the 30%-HCT model. It may be used as a first approach to evaluate e.g., the impact of donor and recipient characteristics on RBC properties.
Sections du résumé
BACKGROUND
The quality of red blood cells (RBCs) stored in red cell concentrates (RCCs) is influenced by processing, storage and donor characteristics, and can have a clinical impact on transfused patients. To evaluate RBC properties and their potential impact in a transfusion setting, a simple in vitro-transfusional model has been developed.
MATERIALS AND METHODS
Transfusion was simulated by mixing a washed RBC pool from two male-derived RCCs stored at 4°C with a pool of 15 male-derived fresh frozen plasma (FFP) units, representing the recipient, at a hematocrit (HCT) of 30% ("control" setting) or 5% (alternative model). The mixtures were incubated at 37°C, 5% of CO
RESULTS
The 5%-HCT model restored the 2,3-DPG level and maintained the ATP level. Furthermore, glucose consumption and corresponding lactate production were increased in the 5%- vs the 30%-HCT condition. Lower hemolysis was observed with 5%-HCT, but only at day 2. However, morphological analysis by digital holographic microscopy (DHM) revealed a decreased fraction of discocytes at 5% rather than at 30% of HCT at storage day 2 but at day 43, the trend was inverted. Concordantly, RBCs incubated at 5% of HCT were more deformable than at 30% at day 43 (p<0.0001).
DISCUSSION
Higher metabolic activity of RBCs in the 5%-HCT condition was promoted by a higher glucose availability and limited cell-waste accumulation. The conditions of the new proposed model thus enabled rejuvenation of RBCs and maintained them in a physiological-close state in contrast to the 30%-HCT model. It may be used as a first approach to evaluate e.g., the impact of donor and recipient characteristics on RBC properties.
Identifiants
pubmed: 36346887
pii: 2022.0086-22
doi: 10.2450/2022.0086-22
pmc: PMC10335337
doi:
Substances chimiques
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
277-288Références
Sci Rep. 2019 May 1;9(1):6771
pubmed: 31043643
J Lab Clin Med. 1969 May;73(5):722-33
pubmed: 5779258
Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E836-48
pubmed: 19690067
Microsc Microanal. 2017 Jun;23(3):607-617
pubmed: 28480839
Microvasc Res. 2010 Jan;79(1):47-55
pubmed: 19837099
ASAIO J. 1997 Sep-Oct;43(5):M571-5
pubmed: 9360109
Vox Sang. 2017 Oct;112(7):638-647
pubmed: 28833258
Blood Transfus. 2021 May;19(3):224-236
pubmed: 33085592
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Free Radic Biol Med. 2016 Jul;96:152-65
pubmed: 27094493
Blood. 2016 Sep 29;128(13):e43-50
pubmed: 27554084
Blood Adv. 2017 Jun 27;1(15):1132-1141
pubmed: 29034365
J Appl Physiol Respir Environ Exerc Physiol. 1977 Jun;42(6):928-34
pubmed: 18437
Curr Opin Anaesthesiol. 2020 Apr;33(2):234-239
pubmed: 31876784
Adv Med Sci. 2013;58(1):134-42
pubmed: 23640945
Front Physiol. 2022 Feb 08;13:840995
pubmed: 35211035
Blood Transfus. 2019 Jan;17(1):27-52
pubmed: 30653459
Blood. 2021 Apr 29;137(17):2285-2298
pubmed: 33657208
Front Physiol. 2018 Jun 01;9:656
pubmed: 29910743
Transfusion. 2017 Feb;57(2):325-336
pubmed: 27813142
Front Physiol. 2018 Dec 19;9:1835
pubmed: 30618840
Front Physiol. 2020 Dec 23;11:616457
pubmed: 33424640
Transfusion. 2008 Oct;48(10):2096-105
pubmed: 18631166
Transfusion. 2000 Nov;40(11):1384-7
pubmed: 11099669
Transfus Apher Sci. 2015 Jun;52(3):270-6
pubmed: 25982219
Sci Rep. 2020 May 7;10(1):7727
pubmed: 32382026
Opt Lett. 2005 Mar 1;30(5):468-70
pubmed: 15789705
Transfusion. 2021 Mar;61(3):903-918
pubmed: 33381865
Transfusion. 2014 Aug;54(8):2055-63
pubmed: 24601981
Vox Sang. 2010 Feb;98(2):116-23
pubmed: 19719459
Front Mol Biosci. 2016 Mar 30;3:11
pubmed: 27066491
Blood Transfus. 2021 Jul;19(4):300-308
pubmed: 32955427
Haematologica. 2020 Jan 23;106(1):238-249
pubmed: 31974203
Br J Haematol. 2008 May;141(4):549-56
pubmed: 18419623
Proteomics Clin Appl. 2016 Mar;10(3):257-66
pubmed: 26548766
Philos Ethics Humanit Med. 2009 Jan 15;4:2
pubmed: 19146696
Front Physiol. 2021 Sep 22;12:722896
pubmed: 34690797
Vox Sang. 2014 Feb;106(2):153-60
pubmed: 23992472
Blood Transfus. 2017 May;15(3):239-248
pubmed: 28518051
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31581149
Int J Mol Sci. 2013 May 08;14(5):9848-72
pubmed: 23698771
Blood. 2012 Feb 16;119(7):1757-67
pubmed: 22117051
Haematologica. 2021 May 01;106(5):1290-1302
pubmed: 32241843
Vox Sang. 2021 Jan;116(1):60-70
pubmed: 32918773
J Clin Invest. 1969 May;48(5):795-809
pubmed: 4388591
Transfusion. 2017 Apr;57(4):1007-1018
pubmed: 28150311
J Trauma Acute Care Surg. 2014 Aug;77(2):198-201
pubmed: 25058241
Transfus Clin Biol. 2021 Nov;28(4):397-402
pubmed: 34464712
Metabolites. 2020 May 29;10(6):
pubmed: 32486030
Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3038-42
pubmed: 17307994
Vox Sang. 2016 Jul;111(1):8-15
pubmed: 26991891
J Proteomics. 2012 Dec 5;76 Spec No.:181-93
pubmed: 22580360